OVERVIEW

Taking Control of Your Diabetes (TCOYD) Making the Connection (MTC) Virtual Conference is organized by Taking Control of Your Diabetes (TCOYD) and will be held on Nov 07, 2020.

Accreditation:
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Pharmacist Accreditation Statement:
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation:
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-20-092-L01-P)

Description:
An immersive, interactive LIVE CME conference experience for Healthcare Professionals FROM AROUND THE WORLD…with additional speakers, varied on-demand lectures and even more opportunities for networking and Q&A!

They are bringing you a one-of-a-kind virtual educational experience where you can feel the excitement and interactivity of an in-person event from the comfort of your own home. Take part in discussions on the most ground-breaking topics in treating type 1 and type 2 diabetes to open two-communication with your patients and improve long-term outcomes—presented by our world-renowned speakers with real experience (many who live with diabetes themselves)! Don’t forget to interact with our cutting-edge exhibitors and network with our worldwide community of healthcare professionals.

*There is always more to learn-on-demand lectures vary for every MTC Virtual PLUS Event so no two will ever be the same.

What you will learn:
We focus on four distinct areas of the most cutting-edge diabetes management strategies:
• Patient-provider relationships with a focus on communication methods to improve adherence and persistence
• Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
• Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact
• Time in range and the unmet needs of type 1 diabetes

Learning Objectives:
At course completion, participants should be able to:
• Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.
• Develop individualized treatment strategies based on the living standards of care and patient characteristics.
• Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.
• Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.
• Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).
• Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.
• Design a treatment plan for multiple daily injection regimens and insulin pump therapy.
• Explain how to interpret continuous glucose monitoring (CGM) data.
• Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.
• Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
• Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.